RESUMO
RESUMEN La peritonitis esclerosante encapsulante es una rara entidad de baja incidencia. Su fisiopatología no está clara, reconociéndose dos tipos: idiopática y secundaria, esta última generalmente como complicación de la diálisis peritoneal. Su diagnóstico suele ser tardío manifestándose con clínica de obstrucción intestinal. Es importante conocer los signos radiológicos. Asocia una alta mortalidad, por lo que es fundamental sospecharla precozmente e incluirla en el diagnóstico diferencial de los cuadros de obstrucción intestinal. Presentamos el caso de una obstrucción intestinal como forma de presentación de una peritonitis esclerosante encapsulante.
ABSTRACT Sclerosing encapsulating peritonitis is a rare condition with a low incidence rate. The pathophysiology of this disease is not clear, though two types are distinguished: idiopathic and secondary; the latter usually occurs as a peritoneal dialysis complication. The diagnosis of the condition is usually delayed and it presents with intestinal obstruction. It is important to know the X-ray findings. This disease is associated with a high mortality rate; therefore, early detection and a differential diagnosis in cases of intestinal obstruction are important. We report a case of intestinal obstruction as a clinical manifestation of sclerosing encapsulating peritonitis.
RESUMO
BACKGROUND: This study focuses on the main complication associated with peritoneal dialysis, peritonitis. Its relevance derives from its high morbidity, the negative effect it has on the peritoneum as a dialysis membrane and its financial cost. METHODS: Analytical, non-interventional, observational cohort study, whose main objective is the analysis of peritonitis in patients on peritoneal dialysis in Andalusia from 1 January 1999 to 31 December 2017, with a total of 2904 peritonitis cases. The database used is the Andalusian Autonomous Transplant Coordination Information System (SICATA). OBJECTIVES: To ascertain how the rate of peritonitis is evolving in our community, analyse descriptive data pertaining to patients and peritonitis, ascertain the course of these infectious complications and analyse the factors that influence these cases of peritonitis and their outcomes: germ, hospitalisation and date. RESULTS: The rate of peritonitis decreased progressively during the study period, from 0.7 peritonitis per patient in 1999 to 0.33 at the end of the period. Most infections were treated on an outpatient basis (72.5%). The most common germs were Gram-positive (55.9%), including coagulase-negative staphylococci (28.1%). Most cases of peritonitis progressed to healing (77.8%). The factors that significantly influence the need for hospitalisation and peritonitis progression were the causative germ and associated exit site infection. CONCLUSIONS: In our population, the rate of peritonitis decreased progressively during the study period, meeting guideline recommendations.
